Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | CFD | P00746 | 1/20 | 0.52 |
| ▸ | ELANE | P08246 | 7/20 | 0.46 |
| ▸ | OGT | O15294 | 1/20 | 0.46 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.42 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.42 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.42 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.42 |
| ▸ | DAO | P14920 | 1/20 | 0.42 |
| ▸ | NOS1 | P29475 | 3/20 | 0.41 |
| ▸ | NOS2 | P35228 | 2/20 | 0.41 |
| ▸ | NOS3 | P29474 | 1/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3498795 | 0.81 | F2 (0.52) | F2CFDELANEOGTPDGFRA | |
| SCHEMBL4509421 | 0.79 | F2 (0.49) | F2CFDELANEOGTPDGFRA | |
| SCHEMBL434293 | 0.79 | OGT (0.50) | F2CFDOGTPDGFRAMAPK8 | |
| SCHEMBL1203402 | 0.78 | F2 (0.52) | F2CFDELANEOGTPDGFRA | |
| SCHEMBL17203101 | 0.78 | F2 (0.52) | F2CFDELANEOGTPDGFRA | |
| SCHEMBL147448 | 0.78 | F2 (0.52) | F2CFDELANEOGTDAO | |
| SCHEMBL4492747 | 0.78 | NOS1 (0.44) | F2CFDOGTPDGFRAMAPK8 | |
| SCHEMBL3987671 | 0.78 | F2 (0.52) | F2CFDOGTPDGFRAMAPK8 | |
| SCHEMBL5310423 | 0.78 | F2 (0.52) | F2CFDOGTPDGFRAMAPK8 | |
| SCHEMBL1559364 | 0.77 | ABCG2 (0.54) | F2CFDELANEOGTAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120079371-A | Oxygen vacancy-containing tungsten trioxide catalyst and preparation method and application thereof | 南京理工大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119098205-A | Nitrogen-doped porous carbon-loaded cobalt monoatomic catalyst and preparation method and application thereof | 南京理工大学 | 2024-12-10 | — | — | CN | claimed |
| CN-118910629-A | Electrochemical synthesis method of quinazolinone derivative | 齐齐哈尔医学院 | 2024-11-08 | — | — | CN | claimed |
| CN-118727475-A | Room temperature salt-free rapid reactive dyeing and recycling method suitable for cellulose fibers | 绍兴劲草化工有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-117625272-A | Gear oil composition | 中国石油化工股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117625250-A | Scale inhibition composition and application thereof | 中国石油化工股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117625288-A | Lubricating oil composition special for unmanned aerial vehicle | 中国石油化工股份有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-117603144-A | Synthesis method of polysubstituted quinazolinone | 常熟泓德生物科技有限公司 | 2024-02-27 | — | — | CN | claimed |
| CN-116063589-A | Soot ashless dispersant, and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-110372611-B | Method for selectively synthesizing polysubstituted dihydro quinazolinone or quinazolinone | 常熟理工学院 | 2021-05-04 | — | — | CN | claimed |
| CN-110372611-A | A kind of method of the polysubstituted dihydroquinazoline ketone of selectivity synthesis or quinazolinone | 常熟理工学院 | 2019-10-25 | — | — | CN | claimed |
| CN-1257161-C | Meptazinol prodrug and its salts and its production method | UNIV FUDAN (CN) | 2006-05-24 | — | — | CN | claimed |
| CN-1569839-A | Meptazinol prodrug and its salts and its production method | UNIV FUDAN (CN) | 2005-01-26 | — | — | CN | claimed |
| EP-4727923-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | University of Georgia Research Foundation, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260098012-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | UNIV GEORGIA (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4652154-A1 | NOVEL ALPK1 INHIBITORS | Pyrotech (Beijing) Biotechnology Co., Ltd. (CN) | 2025-11-26 | — | — | EP | disclosed |
| US-4346032-A | ANTIDOTES TO OVERDOSES OF BENZODIAZEPINE TRANQUILIZERS | HOFFMANN-LA ROCHE INC. (US) | 1982-08-24 | — | — | US | disclosed |
| EP-0049711-A1 | Process for the production of nitro-amino-benzenes | BAYER AG (DE) | 1982-04-21 | — | — | EP | disclosed |
| US-4316839-A | Imidazodiazepine derivatives | HOFFMAN-LA ROCHE INC. (US) | 1982-02-23 | — | — | US | disclosed |
| EP-0027214-A1 | Imidazodiazepine derivatives, process and intermediates for their preparation, medicaments containing them and their therapeutic application | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098012-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | CD47, SLC11A2, G6PD | F2 1060/4885CFD 398/4885ELANE 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.